Krystal Biotech buy Jefferies Financial Group Inc.
Start price
05.03.25
/
50%
€166.55
Target price
05.03.26
€228.54
Performance (%)
34.31%
End price
06.03.26
€223.70
Summary
This prediction ended on 06.03.26 with a price of €223.70. With a performance of 34.31% the BUY prediction by Jefferies_Financial_ was a big success. Jefferies_Financial_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 0.139% | 0.139% | 27.418% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $245.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten